drugset / Trial / NCT01441414
PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma
RandomizedOpen-labelTreatment
Summary
To evaluate the combination of PF-04856884 (CVX-060) in combination with Axitinib (AG-013736) in patients that have received one prior systemic regimen for metastatic renal cell carcinoma (mRCC) vs. axitinib alone.
Timeline
- Start
- 2011-11-21
- Primary completion
- 2014-03-27
- Completion
- 2014-03-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Axitinib | Small molecule | 5 mg | Oral |
| Subject | CVX-060 | Protein / enzyme biologic | 15 mg/kg | Intravenous |